Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Addiction. 2021 Jul 28;117(2):411–424. doi: 10.1111/add.15630

Figure 3.

Figure 3

Average cost of HCV screening and treatment using DAA-based regimens by HIV status. Costs are presented in 2018 $. DAA = direct-acting antiviral; DOT = direct-observed therapy; HCV = hepatitis C virus; HIV = human immunodeficiency